Mirina, Marina wrangle over company name

Mirina Corporation has filed a trademark infringement lawsuit against Marina Biotech, according to Xconomy. The two developers are based in Seattle and Bothell, WA, respectively. Marina Biotech was known until recently as MDRNA. But after completing a $46 million merger with Cequent earlier this year, the company chose to rename itself to reflect its RNA development work. Prior to its iteration as MDRNA, the company was known as Nastech and developed nasal-spray...

Biotech start-ups tout plans for microRNA and cardio drugs

A pair of biotech start-ups raised their flags this morning. Out in Seattle, Mirina announced that it had raised an undisclosed amount of money in a Series A-1 that would cover its burn rate for the next 12 to 15 months. And a new start-up dubbed LipimetiX has announced its debut in Boston. Versant Ventures led the round for Mirina, which will use the money--however much it is--to further explore development of microRNA therapies. Xconomy notes that while Mirina is keeping the financial details...